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The neural retina is an excellent model for studies in neurogenetic
disease [1–4]. There are over 200 mapped loci for genetic eye diseases
for which simple Mendelian mutations have been found in approxi-
mately 170 genes (http://www.sph.uth.tmc.edu/retnet/sum-dis.htm).
Genetic mutations lead to visual impairment or blindness in most, and
such patientsmay be characterized functionally (by visual acuity), elec-
trophysiologically (by electroretinogram), and also morphologically
through fundoscopic exam. Further still, the cell types of the neural ret-
ina are exquisitely well characterized morphologically and biochemi-
cally [5]. The approachable layered structure of the neural retina
provides critical advantages for experimental studies of genetic eye dis-
ease. Finally, in a majority of situationsmousemodels of human neuro-
genetic diseases have been highly informative [6]. Thereby, the neural
retina speciﬁcally offers an important opportunity to examine some of
the fundamental features of neurogenetic disease.
Novel, massively-parallel, high-throughput sequencing technolo-
gies provide an opportunity for genome-wide observations of the
transcriptional architecture of retina genes in a fashion which has
not be been previously attainable. The transcriptome is the completeset of transcripts in a cell at a speciﬁc stage or under given physiolog-
ical condition [7]. Genome-wide characterization of the retinal tran-
scriptome is central to understanding cell development, physiology
and disease [2,8,9]. High-throughput mRNA sequencing (RNA-Seq)
allows simultaneous transcript discovery and abundance estimation
[10]. Until recently, microarray platforms (hybridization-based tech-
nologies) as well as Serial Analysis of Gene Expression (SAGE) have
been used, each with distinct strengths and weaknesses [8,9,11–13].
RNA-Seq utilizing next generation sequencing technology (NGS) has
overcome many of the challenges of the previous technologies [14,15].
NGS data have a wide dynamic range of transcript expression for quan-
tiﬁcation and identiﬁcation of low abundance transcripts. Furthermore,
RNA-Seq discovers all transcripts present in the library within the con-
straints of the depth of coverage. With microarray technologies, tran-
scripts will only be detected based on prior knowledge as required for
probe placement [16]. Also, the size of transcripts may be accurately
measured by RNA-seq, as opposed to array hybridization which does
not provide information on transcript size.
In this study, we have applied high-throughput RNA sequencing to
all mRNAs from the murine neural retina. These data may serve as a
resource for the community interested in gene expression in the neu-
ral retina. In addition, our analyses have revealed fundamental as-
pects of the transcriptional architecture of disease genes. We clearly
demonstrate that genes that are associated with retinal disease are
among the most highly expressed and largest in the transcriptome.
We also present other features of interest regarding the transcrip-
tome including that the retina appears to utilize a distinct subset of
synaptic vesicle genes, and also, that there is a persistence of expres-
sion of many “neurodevelopmental” genes into adulthood. The data
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for in depth study of gene expression.
2. Results
2.1. Genome-wide transcript proﬁling in mouse neural retina by RNA-seq
To gain a genome-wide view of gene expression in the neural retina,
high-throughput RNA sequencing (RNA-seq) was performed on adult
neural retina dissected free from other ocular tissue at postnatal day 21.
Two distinct cDNA libraries were prepared to assure biologic replication.
Each library was derived from poly(A)+transcripts pooled within one
litter of mouse pups from the CD1 line acquired from Charles River Lab-
oratories. Each librarywas constructed frompooling 8 neural retinae dis-
sected free of other ocular tissue. Libraries were sequenced on the
Illumina GAIIx instrument by paired-end chemistry with results as de-
scribed in Table 1. A total of 49,305,140 reads were obtained for library
EMA and 50,818,317 for library EMB. Coverage plots of the ﬁve most
abundant genes in addition to the transcription factor Crx are shown in
Figs. 1A–F. Quality scores for each lane of sequence were plotted sepa-
rately and all sequence was determined to be of high quality with scores
above 32 (Supplementary Fig. 1). A transcriptome analysis path was
adopted as shown in Fig. 2. Sequenced reads were aligned to the Mus
musculus (July 2007 NCBI37/mm9) using Bowtie [17]. Splice junctions
were then identiﬁed using TopHat [18] and transcript abundances were
calculated using Cufﬂinks [10] (Fig. 2). Gene annotations were derived
from the Aceview database (Mouse Jun07) [19]. For EMA, in total
45.2 million reads were aligned to the genome with 40 million mapping
to unique locations, representing N40× sequence coverage of the 60 Mb
M.musculus transcriptome. Data for EMBwere similar (Table 1). Aceview
represents a well established model of gene annotation for mouse and is
among the most comprehensive set of gene models available. Other an-
notations include RefSeq, Vega, Ensembl, Gene Trap, Geneid, MGC and
Genescan are available from the UCSC browser (www.genome.ucsc.
edu). For purposes of completeness, we compared an analysis across
these two databases. Concordance for expression levels when reads
were aligned to Aceview and UCSC gene models was high and plotted
with R-squared values of over 0.97 for EMA (Supplementary Fig. 2a).
Comparison of expression levels obtained for EMB when mapped to the
alternative reference libraries showed a similar concordance of ﬁndings
with R-squared values of 0.94 (data not shown).
Comparison of results of the two libraries, i.e. biologic replicates,
EMA and EMB, also showed a high degree of concordance. As de-
scribed, each library was sequenced to a similar depth of coverage
(Table 1). Utilizing the analysis path as shown (Fig. 2), 29,580 tran-
scripts were identiﬁed in EMA and 31,685 transcripts were identiﬁed
in EMB. 70% of all transcripts identiﬁed were discovered in both EMA
and EMB, and expression levels showed high concordance (R-squared
of 0.86) across trials (Supplementary Fig. 2b). Transcripts which we
discovered in only one of EMA or EMBwere dropped from general an-
alyses described below. In total, 15,251 known genes and 20,558
transcripts were coordinately identiﬁed using RNA-Seq in our two li-
braries from mouse retina. Two or more isoforms were found in 3655
genes. The complete list of genes with alternative splicing, transcript
sizes and abundances is included in Supplementary Table 1.Table 1
RNA sequencing in murine neural retina.
Library Read
length
(bp)
Reads
produced
(million)
Sequenced
bases
(Mb)
Aligned
reads
(millions)
Reads
aligned
uniquely
(millions)
Unique reads
overlapping
exons (%)
EMA 60 49.3 2958.3 45.2 40.0 83.1
EMB 60 50.8 3049.1 45.2 41.7 80.72.2. Transcripts associated with disease are among the most abundant
and largest in the transcriptome
Gene abundances were quantiﬁed in Fragments Per Kilobase of exon
model perMillion mapped fragments (FPKM) and exhibited a range be-
tween 0.125 and 2481.5 (Table 2) [10]. Based on transcripts discovered
in both replicates the mean and median expression levels were 10.07
FPKM and 4.11 FPKM respectively. The twenty most abundantly
expressed genes are listed in Table 3. Genes related with eye diseases
were taken from Retinal Information Network (RetNet) (http://www.
sph.uth.tmc.edu/retnet/sum-dis.htm)which list 159 genes in total associ-
ated with retinal disease as of 12/5/2010. Across both biologic replicates,
transcripts for 114 genes associated with retinal disease were identiﬁed
(127 in EMA and 132 in EMB), and many of these genes were among
the most abundantly expressed. For example, the three genes with high-
est expression in both replicates were three retinal disease genes: rho-
dopsin (Rho) (2481.5+/−232.01 FPKM) is associated with dominant
retinitis pigmentosa, dominant congenital stationary and night blindness;
guanine nucleotide-binding protein G(t) subunit alpha-1 (Gnat1) (also
known as the transducin alpha-1 chain) (2092.48+/−281.38 FPKM) is
associated with dominant congenital stationary and night blindness;
and retinal S-antigen (Sag) (1046.75+/−393.9 FPKM) is associated
with recessive Oguchi disease and recessive retinitis pigmentosa
(Table 4). Further still, while disease genes represent less than 1% of the
genes in the transcriptome (114 total disease genes of 15251 genes),
30% (6 of 20) of the 20 most highly expressed genes were associated
with disease (Figs. 3A, B and Table 3). Statistical analysis indicates clearly
that the expression level of disease genes is signiﬁcantly higher than those
of non-disease genes (Chi-Square 72.07, DF=1, pb0.0001). The gene ex-
pression scores demonstrated a profound skewness calculated as 40.79
using the univariate procedure; however, the statistically signiﬁcance
was strongly maintained when alternative, non-parametric test proce-
dures were utilized which do not assume a normalized data distribution
such as the Wilcoxon Rank Sums/Kruskal–Wallis (Chi-Square 72.07,
DF=1, pb0.0001).
Of the 159 disease genes identiﬁed in the RetNet database (http://
www.sph.uth.tmc.edu/retnet/sum-dis.htm), 126 were identiﬁed con-
cordantly in our RNA-seq experiments (Supplementary Table 2). Six
genes were discovered only in one of the two replicates. The 33
genes which were not identiﬁed are listed in Supplementary Table
3. Of these 33 genes, 18 genes which were not identiﬁed in neural ret-
ina had cogent rationale for the absence. For example, ten of these
genes are known to be expressed exclusively in retinal pigment epi-
thelium, lens, vitreous, vascular elements or exclusively during devel-
opment (i.e. are not expressed in adult neural retina). (Recall that our
tissue sample was neural retina dissected free of other ocular tissue.)
Several (an additional three) clearly function at a systemic level with
extra-ocular gene expression, for example, complement factor H
(Cfh) or Abcc6 which are secreted by non-neuronal cells. Finally,
ﬁve of the known disease genes which were not identiﬁed were strict
mitochondrial expressed genes.
We sought to identify differences between the most abundantly
expressed disease genes and those which were not abundantly
expressed. We performed pathway analysis on the most abundant
and least abundant twenty genes using Gene Ontology Enrichment
Analysis Software Toolkit (GOEAST)[20]. There were several similari-
ties between the most highly expressed disease genes as compared to
the least abundantly expressed disease genes (Supplementary Tables
4 and 5 as well as Supplementary Figs. 3 and 4 for most abundant and
least abundant twenty disease genes, respectively). Among the com-
mon featureswere biological processeswhich included sensory percep-
tion, development of retinal structures and retinol metabolic processes.
Also in common were cellular processes which involved photoreceptor
outer segment, inner segment and connecting cilium. Differences in-
cluded in the top group phototransduction (pb2.46e−10) which in-
volved four of the top twenty genes, nucleotide metabolism such as
Fig. 1. Coverage plots of most abundant genes (A) Rho, (B) Gnat1, (C) Sag, (D) Gnb1, (E) Gngt1 and (F) Crx.
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Fig. 2. The data analysis steps in the computational pipeline to analyze RNA-Seq data from mouse retina to obtain expressed known transcripts with expression levels and number
of isoforms as well as to extract disease genes.
Table 3
Most highly expressed known genes from Aceview database.
Gene Number of isoforms Average expression (FPKM)
Rho 1 2481.5±164.1
Gnat1 2 2092.5±199
Sag 2 1046.7±278.5
Gnb1 2 625.5±158.5
Gngt1 1 560.7±73.5
Hcn1 1 546.8±165.5
Loc218963 1 482.8±36.1
Rasana 1 409.9±100.2
Jarid2 4 386.3±19 .0
Yukowara 1 380.1±97 .0
Rbp3 1 375.5±13.8
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cluded three genes, and rod cell development (pb1.8e−4) although
this last category only involved a single gene of the twenty. Pathways
which emerged for the disease genes that were least abundantly
expressedwhichwere not sharedwith the top genes, includedmolecu-
lar mediator of immune response (pb2.29e−4) involving two genes,
extracellular matrix genes (pb7.7e−4) involving three genes, and
cone cell differentiation (pb2.79e−4) although this only involved a sin-
gle gene.
On average, transcripts which have been implicated in disease were
also larger thannon-disease transcripts andhadmore alternative splicing
events. For example, transcripts associatedwith diseasewere found to be
4333.4 kb on average as compared to 3323.1 kb for non-disease tran-
scripts (Chi-Square 13.3638, DF=1, p=3e−4). Further still, we noticed
that transcripts associated with disease showed a small but statistically
signiﬁcant increase in alternative transcripts (number of transcripts
were 1.55 and 1.35 for disease and non-disease genes, respectively)
(Chi-Square 7.4753, DF=1, p=6.3e−3). To address the possibility that
the increased transcript size and increased transcript numberwere corre-
lated with transcript expression level, we conducted correlation studies
of these factors. Across the full dataset, we did not identify a correlationTable 2
Summary analysis of transcript expression and splicing.
Range Mean Median
Gene expression (FPKM) 0.125–2481.5 10.07 4.11
Number of transcripts/gene 1–8 1.35 1between transcript abundance and size (Pearson's coefﬁcient=0.0007),
nor transcript size and alternative transcripts (Pearson's coefﬁcient=
−0.093), nor abundance and alternative transcripts (Pearson's coefﬁ-
cient=−0.036). Thereby, the increase in abundance, size and transcript
number of genes associated with disease appears to be a novel and fun-
damental feature of disease genes in the retina transcriptome.Pde6g 1 370.4±237.8
Prph2 1 367.9±70.8
Pdc 1 345.1±78.9
Cpe 1 340±6.7
Seyjaw 1 334.8±132.8
Hexb 1 321.1±309.9
Snap25 3 320.7±27.5
Surera 1 296.0±91.6
Syp 1 276.0±25.1
Table 4
Most highly expressed known genes related with eye diseases.
Gene Isoforms Average
Expression
(FPKM)
Disease
Rho Rho.a 2481.5±164.1 Retinitis pigmentosa, congenital stationary
night blindness
Gnat1 Gnat1.g 2092.5±199.0 Congenital stationary night blindness
Gnat1.a 136.9±136.3
Sag Sag.h 1046.7±278.5 Oguchi disease, retinitis pigmentosa
Sag.i 214.8±36.3
Rbp3 Rbp3.a 375.5±13.8 Retinitis pigmentosa
Pde6g Pde6g.b 370.4±237.8 Retinitis pigmentosa
Prph2 Prph2.a 367.9±70.8 Retinitis pigmentosa, macular dystrophy, adult
vitelliform macular dystrophy
Pde6a Pde6a.a 210.8±0.8 Retinitis pigmentosa
Pde6a.c 106.2±27.0
Pde6b Pde6b.h 169.0±143.1 Retinitis pigmentosa, congenital
Pde6b.a 58.1±2.1 Stationary night blindness
Pde6b.b 4.8±0.0
Rdh12 Rdh12.b 156.1±3.5 Leber congenital amaurosis with severe
childhood retinal dystrophy
Prom1 Prom1.o 143.4±13.0 Macular dystrophy, bull's-eye, retinitis
Prom1.k 12.2±3.6 Pigmentosa with macular degeneration,
Prom1.m 0.7±0.2 Stargardt-like macular dystrophy,
Prom1.l 0.4±0.2 Macular dystrophy, bull's-eye, cone rod
dystrophy
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studies from previous methods
With regard to cell-type speciﬁc gene expression, we compared our
dataset to previously published transcriptome studies. For example, 43
genes had previously been identiﬁed by SAGE to be rod-enriched [8].
We identiﬁed 42 of these previously identiﬁed genes in our dataset.
The average transcript level for these genes is 227.0 FPKM with the
range from 1.3 to 2481.5 FPKM (Supplementary Table 6). With regardFig. 3. Comparison of disease and non-disease genes expressed in EMA and EMB. (A) Expr
transcript length (bp), (C) Analysis of gene expression level (FPKM) based on gene categorto bipolar cells, we identiﬁed 71/73 previously identiﬁed genes [21].
The average transcript level for these bipolar genes is 21.5 FPKM with
the range from 0.3 to 125.2 FPKM. For amacrine cells, 86/88 previously
identiﬁed genes were found to be expressed in our dataset [21]. The av-
erage amacrine cell transcript level for these geneswas 33.3 FPKM,with
a range from0.3 to 432.0 FPKM. For ganglion cells, we identiﬁed expres-
sion in 47/49 of the ganglion cell enriched genes previously reported
[22], and the range of gene expression was from 0.2 to 126.9 FPKM
with anaverage expression level of 24.4 FPKM. ForMuller cells, gene ex-
pressionwas noted in 69/70 genes noted to have highestMuller expres-
sion [23]. Average gene expression in Mullers was 39.0 FPKM and
ranged from 0.5 to 226.5 FPKM. Failure to ﬁnd the very small minority
of genes described is attributed to nomenclature discrepancies, i.e.
gene names that were not identiﬁed in AceView and could not be oth-
erwise identiﬁed. In the case of three genes only (Hmgcs1 and Hub1
(Zfp282) in ganglion cells and Prss2 in Mullers), genes noted to be
expressed in previous studies were found not to be expressed in our
mouse dataset. For the ganglion cell genes, thismight reﬂect species dif-
ferences. Of interest, some genes which may be predicted to have very
low gene expression were discovered in our dataset. For example,
Opsin4 (Opn4, melanopsin) is only expressed in a small fraction (1%)
of all ganglion cells (which represent a small fraction of retinal cells)
is detected in both of our trials at levels of 1.3 and 1.4 FPKM. Finally,
to verify that there was not an overabundance of contamination from
retinal pigment epithelium, seven signature RPE genes were found to
have no expression or very little expression (0.4 FPKM in only one
trial). Our data are therefore consistent with very little contamination
from RPE.
2.4. Alternative splicing observed in 24% of genes
We assessed the extent of alternative splicing and identiﬁed 3655
genes with more than two identical isoforms expressed in both repli-
cates. The number of alternative transcripts per gene was observed toession levels in FPKM versus transcript number, (B) expression levels in FPKM versus
y, (D) Histogram of number of genes expressed in given GO Term category.
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that the isoform be identiﬁed in both replicates), we identiﬁed alterna-
tive splicing in 24% of genes. The average abundance of themost highly
expressed transcript for genes with multiple isoforms was 12 FPKM. As
indicated, we did not discover a correlation of number of isoformswith
transcript abundance or size. Genes with the greatest number of tran-
scripts are shown in Table 5. For example, Abca8a has 8 isoforms in
both replicates and the expression of isoforms ranges between 18.4
and 41.9 FPKM.
In order to compare our alternative transcript results with the prior
published results, we curated all data from a Pubmed search on alterna-
tive splicing of retina genes as described in the Materials and methods
section. This search on January 14, 2011 returned 144 references. The
studies of alternative splicing in the literature were performed in a vari-
ety of tissues (i.e. including for example retinal pigmented epithelium),
species and developmental stages. In situations wherein the tissue, spe-
cies, or developmental stageswere similar, the number of transcripts dis-
covered in our study generally agreed or exceeded published reports
(Supplementary Table 7). For example, Crx, Six3 and Nrxn2 were found
in our study to have the same number of transcripts as has been deter-
mined previously in the literature. For other genes with similar experi-
mental conditions, our study identiﬁed more isoforms (concordantly in
both biologic replicates), for example, the RNA-seq experiments identi-
ﬁed four transcripts for Rpgrip1 while a prior report identiﬁed only two
transcripts [24]. Similarly, for Cabp1, RNA-seq identiﬁed ﬁve transcripts
while two were previously documented in the literature [25]. The com-
plete list of transcripts discovered (including those discovered in both
EMA and EMB) is found in Supplementary Tables 8, 9 and 10.We validat-
ed a test set of approximately thirty transcripts by PCRusing exons specif-
ic primers. In a majority of transcripts (greater than 85%), the alternativeTable 5
Genes with greatest number of alternative transcripts.
Gene Number of
isoforms
Isoforms Average expression level
(FPKM)
Abca8a 8 Abca8a.a 42.0±0.5
Abca8a.f 37.3±0.9
Abca8a.e 35.9±3.9
Abca8a.b 30.2±1.9
Abca8a.g 28.8±0.1
Abca8a.d 22.4±0.6
Abca8a.h-unspliced 19.1±0.7
Abca8a.c 18.4±3.4
Med15 7 Med15.o 104.9±11.8
Med15.d 21.5±0.4
Med15.a 11.0±10.1
Med15.n 7.8±0.0
Med15.s 3.4±0.1
Med15.u 2.5±0.1
Med15.i 0.8±0.0
Atp1a1 7 Atp1a1.a 49.9±1.2
Atp1a1.i-unspliced 42.4±1.3
Atp1a1.b 39.2±0.9
Atp1a1.f 37.4±11.9
Atp1a1.j-unspliced 34.4±0.3
Atp1a1.h-unspliced 25.8±4.1
Atp1a1.e-unspliced 14.5±4.6
Wdr1 7 Wdr1.g 35.3±0.5
Wdr1.a 33.9±2.5
Wdr1.h 24.4±0.8
Wdr1.k 17.3±1.1
Wdr1.i 15.8±3.4
Wdr1.j 15.0±2.5
Wdr1.l 9.4±3.7
Anapc1 7 Anapc1.a 22.3±0.3
Anapc1.f 19.0±1.6
Anapc1.j 14.7±0.0
Anapc1.k 12.2±4.5
Anapc1.l 6.8±4.6
Anapc1.b 5.7±2.1
Anapc1.e 2.6±0.5transcripts were identiﬁed by PCR (data not shown). For example, in the
case of gene Rpgrip1 and Cabp1, wherein transcript numbers exceeded
previously reported, all transcripts tested were validated (three of three
for Rpgrip1 and four of four tested for Cabp1) which conﬁrms these new
predictions of transcripts in excess of prior reports. Similarly, for gene
Atp1a1, which was one of the most alternatively spliced genes, seven of
seven transcripts tested were validated by PCR testing.
2.5. Retina uses a distinct subset of synaptic vesicle genes
Genome-wide analysis of transcription using RNA-seq also revealed
several novel features of the retinal transcriptome.We studied genes in
several gene ontology (GO) groups such as axonogenesis, neuron de-
velopment, neurite morphology, neurotransmitter secretion, synap-
tic vesicles, synapse part and voltage-gated channel activity. The
representation of transcripts within these GO categories is shown
in Figs. 3C and D. Interestingly, despite the derivation of the tran-
scriptome from adult tissue 42 out of 68 neuron development
genes (greater than 60%) were expressed in both samples. Expres-
sion level of those genes ranges between 0.5 and 123 FPKM (Supple-
mentary Table 11). Average expression level of neuron development
genes is 18 FPKM. Also 195 genes of 285 neurite morphology genes
(greater than 65%) are expressed adult in both samples and the aver-
age expression level is 14.9 FPKM (Supplementary Table 12). Due to
the fundamental role of voltage-gated ion channels in neuronal
physiology, genes related with this family are expected to be highly
expressed in retina (Supplementary Table 13). A surprisingly large
percentage of these genes, 124 of 179 genes (nearly 70%) deﬁned
to be in this family, were expressed in both of replicates and at
high levels. The most abundant gene in this family and among all
gene families chosen for our study isHcn1, Potassium/sodium hyper-
polarization-activated cyclic nucleotide-gated channel 1 gene and
the average expression level for voltage-gated ion channels was
16.7 FPKM. Synaptic vesicles have critical roles in neurotransmission
in a neuron. It was unanticipated that only 81 out of 265 genes (ap-
proximately 30%) related with synaptic vesicles were discovered.
In spite of the low number of genes expressed in this family, the av-
erage of expression level is quite high (28.4 FPKM) (Supplementary
Table 14). This result supports a very interesting model: the retina
utilizes a relatively speciﬁc and restricted subset of synaptic vesicle
genes.
3. Discussion
We have generated a comprehensive map of retina transcriptome
in mouse using high throughput, paired-end RNA-seq. We are making
these data publically available and anticipate this could be a highly
accessed resource for researchers interested in gene expression in
the neural retina. There have been several transcriptome studies in
retina, all were done by using previous technologies such as microar-
ray and serial analysis of gene expression (SAGE) [8, 9]. Dorrell et al.
reported 2635 known genes in a microarray study on developing
mouse retina [26]. In this study, postnatal mouse retina development
was studied including the postnatal day 21 which is the same sam-
pling day as our study. Using SAGE, Blackshaw et al. reported gene ex-
pression during retinal development, but focused on genes expressed
by mammalian rods [8]. A microarray study done by Livesey et al. fo-
cused on transcriptional network controlled by Crx using cDNA mi-
croarray [27]. Zhang et al. also used cDNA microarray to study the
mouse retinal development from embryonic day 12.5 to postnatal
day 21 [28]. In the present study, we used RNA-seq to accurately
identify transcript abundances (with a broad dynamic range), size
and alternative splicing information in mouse retina at postnatal
day 21. Our study has revealed several novel features of the retina
transcriptome, including in particular the architecture of known reti-
nal disease genes. We identiﬁed 15,251 known genes expressed
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of those were found to have more than 2 isoforms.
The neural retina has a large number of known disease genes which
act in a simple Mendelian fashion (greater than 150 genes) which lead
to visual impairment and blindness (http://www.sph.uth.tmc.edu/
retnet/sum-dis.htm). Few other tissues have such a well characterized
and highly speciﬁc signature of disease genes. These attributes of the
neural retinamake this tissue an excellentmodel to study the transcrip-
tional architecture of neurogenetic disease by genome-wide RNA-seq.
Here we have discovered a number of features of the transcriptional ar-
chitecture of disease genes including disease genes which are among
the most abundantly expressed, and are generally larger with more al-
ternative transcripts than non-disease genes. It is possible that the high
level of expression of disease genes may be a feature of the retina, but
we propose that these attributes may alternatively be fundamental
properties of disease genes. One possible interpretation with regard to
abundance may be that disease genes are commonly expressed in rod
photoreceptors and these cells are among the most abundant cell
types in the murine neural retina, representing greater than 70% of
cells (Lavail 1980; Morrow 1998). While this observation may explain
part of the high abundance of disease genes, the increase in alternative
splicing and the larger size of disease-related genes seem likely inde-
pendent characteristics of the disease gene transcriptional architecture.
More work will be necessary in other neural tissues to examine this re-
sult in greater detail.
Our data provide interesting ﬁndings on alternative splicing in
mouse retina. Alternative splicing occurs in 3655 genes (24%) of the
genes identiﬁed in both libraries with a large number of genes dem-
onstrating over two transcripts. Our ﬁndings are highly consistent
with prior estimates of alternatively splicing in human retina where
alternative splicing has been estimated to be in 26% of retina genes
in a study based on expressed sequence tags (ESTs) [29]. Alternative
splicing events in our study showed high concordance in terms of
gene abundances (R2=0.85, data not shown) yet we anticipate that
our results may represent an underestimate of alternative splicing
given our strict criteria for identifying transcripts in our biologic rep-
licates. However, we have provided the full analysis of the conserva-
tive list of transcripts (discovered in all replicates) and also all
transcripts from individual replicates in Supplementary data.
Finally, genome-wide proﬁling of retinal transcriptome has revealed
other interesting features of retina biology. For example, we noted that
of all the synaptic vesicle genes in the genome, only 30% of such genes
are expressed in the retina; that is, the retina uses a very speciﬁc signa-
ture of synaptic vesicle genes. Further work in different neural tissues
will likely elucidate distinct signatures which may suggest speciﬁc
physiologic properties of neurons in different neuronal circuits. In addi-
tion, the observation that neuronal development genes show persistent
expression in adult tissues is also compelling. This argues that a major-
ity of such genes may have various functions including in neuronal de-
velopment and potentially in the maintenance of neuronal health.
In summary, this study presents the most comprehensive view of
the transcriptome of themurine neural retina to date using novel, mas-
sively-parallel sequencing technologies. Our analysis uses the state-of-
the-art tools for calculations of transcript abundance, size and alterna-
tive splicing. These data are provided as a resource for the community
of researchers studying gene expression in retina.
4. Materials and methods
4.1. Sample collection, library preparation and sequencing
The neural retinawas dissected free of any ocular tissue from 21 day
old CD1 mice which were purchased from Charles River Laboratories.
Poly (A)+transcripts were isolated by following themanufacturer's in-
structions (mirVana™ miRNA Isolation Kit, Ambion®) from dissected
retina. EMA and EMB librarieswere constructed fromduplicate samplesbased on established protocols by Illumina (mRNA Sequencing Sample
Preparation Guide Cat # RS-930-1001). Isolated cDNA libraries were se-
quenced by paired-end chemistry via Illumina GenomeAnalyzer IIx. On
average 50 million of 60 bp reads were obtained from each library.
4.2. Data analysis
Sequencing reads in FASTQ format were mapped to build 37.1 of
the mouse genome as well as splice junctions were identiﬁed using
Bowtie version 0.12.5.0 [17] and TopHat version 1.1.0 [18]. Average li-
brary size and read length were 280 bp and 60 bp paired-end reads,
respectively. Transcript abundances were estimated by using Cuf-
ﬂinks in Fragments per kilobase of transcript per million fragments
sequenced (FPKM) [10]. All transcripts identiﬁed by Cufﬂinks version
0.9.1 were matched to the gene annotations taken from Aceview da-
tabase [19] by Cuffcompare which is a part of Cufﬂinks. Parameters
used to run TopHat and Cufﬂinks are shown in Supplementary Table
18. The program pipeline used for the data analysis is shown in
Fig. 2. Output of this pipeline contains ﬁles with gene annotations,
transcripts, abundances and loci of all transcripts. By using custom-
made scripts, these ﬁles were further analyzed to extract eye disease
genes as well as gene families of interest.
FastQC (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) was
used to check the quality of raw sequence data. Each lane (EMA s_5, EMA
s_6, EMB s_7 and EMB s_8) was analyzed with FastQC and results were
shown in Supplementary Figs. 1A–D. According to FastQC quality scores,
raw sequencing reads of our samples are high quality.
Coverage plots were prepared by using Bedtools program (http://
code.google.com/p/bedtools/). Firstly, the "accepted_hits.bam" ﬁle
which was generated by TopHat was converted into a BEDgraph
ﬁle by Bedtools program. BEDgraph ﬁle was converted into BigWig
ﬁle which was used for visualization on UCSC browser (http://
genome.ucsc.edu/cgi-bin/hgGateway).
4.3. Curation of alternative splicing genes
Pubmed search was performed to search for genes with alterna-
tive splicing isoforms between 1/14/2010 and 1/17/2010. Keywords
such as “alternative splicing of retina genes, alternative splicing iso-
forms in retina” were entered to Pubmed and the abstracts of ﬁrst
100 results were read. If the corresponding gene in the abstract was
expressed in our samples and the abstract indicated experimental
ﬁndings on alternative splicing isoforms, other sections of the article
were examined. Alternative transcripts with solid experimental sup-
port were included in Supplementary Table 7.
4.4. Statistics
Correlation between transcript abundance, size and alternative
transcripts was calculated by Pearson's correlation on Excel. For the
comparison of disease and non-disease genes in terms of expression
level, number of alternative transcripts and transcript length,
NPAR1WAY procedure in SAS was used.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ygeno.2011.09.003.
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